On June 26, 2022, China Center for Food and Drug Inspections (CFDI), a public institution under National Medical Products Administration (NMPA), issue…
On June 20, China National Joint Drug Procurement Office announced the start of the 7th round of volume-based procurement (VBP), covering 59 drugs wit…
On June 8, 2022, China’s Ministry of Ecology and Environment (MEE) issued the Notice on the Adjustment of the Key Tasks Related to the Management of C…
Overview According to the State of the Global Climate 2021 released by the World Meteorological Organization, human activities have increased the conc…
On June 2, China National Medical Products Administration (NMPA) released the draft of Good Manufacturing Practice of Pharmaceutical Packaging Materia…
In addition to the addition of substances for mandatory GHS-related obligations under ISHL, the MHLW amended the Ordinance on Industrial Safety and He…
As more sodium hyaluronate products emerge on the market, China is going to update its regulations to better guide the registration and supervision of…
On May 20, China National Medical Products Administration (NMPA) released the revised draft of the Announcement on the Administrative Classifications …
On May 9, China National Medical Products Administration (NMPA) released the draft of the revised Regulations for Implementation of the Drug Administr…
Generic drugs comprise a significant part of China\’s pharmaceutical market. In 2020, 63% of marketed drugs in China were generics. The Chinese …
